Measles Virus as an Oncolytic Immunotherapy

por Engeland, Christine E., Ungerechts, Guy
Publicado en Cancers (Basel) (2021)

Oncolytic viruses encoding bispecific T cell engagers: a blueprint for emerging immunovirotherapies

por Heidbuechel, Johannes P. W., Engeland, Christine E.
Publicado en J Hematol Oncol (2021)

The Cellular Protein Lyric Interacts with HIV-1 Gag

por Engeland, Christine E., Oberwinkler, Heike, Schümann, Michael, Krause, Eberhard, Müller, Gerd A., Kräusslich, Hans-Georg
Publicado 2011

Tumor-Specific Delivery of Immune Checkpoint Inhibitors by Engineered AAV Vectors

por Reul, Johanna, Frisch, Janina, Engeland, Christine E., Thalheimer, Frederic B., Hartmann, Jessica, Ungerechts, Guy, Buchholz, Christian J.
Publicado en Front Oncol (2019)

Fighting Cancer with Mathematics and Viruses

por Santiago, Daniel N., Heidbuechel, Johannes P. W., Kandell, Wendy M., Walker, Rachel, Djeu, Julie, Engeland, Christine E., Abate-Daga, Daniel, Enderling, Heiko
Publicado en Viruses (2017)

Granulocyte-Macrophage Colony-Stimulating Factor-Armed Oncolytic Measles Virus Is an Effective Therapeutic Cancer Vaccine

por Grossardt, Christian, Engeland, Christine E., Bossow, Sascha, Halama, Niels, Zaoui, Karim, Leber, Mathias F., Springfeld, Christoph, Jaeger, Dirk, von Kalle, Christof, Ungerechts, Guy
Publicado 2013

Oncolytic measles virus encoding interleukin-12 mediates potent antitumor effects through T cell activation

por Veinalde, Rūta, Grossardt, Christian, Hartmann, Laura, Bourgeois-Daigneault, Marie-Claude, Bell, John C., Jäger, Dirk, von Kalle, Christof, Ungerechts, Guy, Engeland, Christine E.
Publicado en Oncoimmunology (2017)

Immunological Effects and Viral Gene Expression Determine the Efficacy of Oncolytic Measles Vaccines Encoding IL-12 or IL-15 Agonists

por Backhaus, Paul S., Veinalde, Rūta, Hartmann, Laura, Dunder, Jessica E., Jeworowski, Lara M., Albert, Jessica, Hoyler, Birgit, Poth, Tanja, Jäger, Dirk, Ungerechts, Guy, Engeland, Christine E.
Publicado en Viruses (2019)

MicroRNA-sensitive oncolytic measles virus for chemovirotherapy of pancreatic cancer

por Singh, Hans Martin, Leber, Mathias Felix, Bossow, Sascha, Engeland, Christine E., Dessila, Jan, Grossardt, Christian, Zaoui, Karim, Bell, John C., Jäger, Dirk, von Kalle, Christof, Ungerechts, Guy
Publicado en Mol Ther Oncolytics (2021)

CTLA-4 and PD-L1 Checkpoint Blockade Enhances Oncolytic Measles Virus Therapy

por Engeland, Christine E, Grossardt, Christian, Veinalde, Rūta, Bossow, Sascha, Lutz, Diana, Kaufmann, Johanna K, Shevchenko, Ivan, Umansky, Viktor, Nettelbeck, Dirk M, Weichert, Wilko, Jäger, Dirk, von Kalle, Christof, Ungerechts, Guy
Publicado en Mol Ther (2014)

Enhanced Control of Oncolytic Measles Virus Using MicroRNA Target Sites

por Leber, Mathias Felix, Baertsch, Marc-Andrea, Anker, Sophie Caroline, Henkel, Luisa, Singh, Hans Martin, Bossow, Sascha, Engeland, Christine E., Barkley, Russell, Hoyler, Birgit, Albert, Jessica, Springfeld, Christoph, Jäger, Dirk, von Kalle, Christof, Ungerechts, Guy
Publicado en Mol Ther Oncolytics (2018)

Measles Vaccines Designed for Enhanced CD8(+) T Cell Activation

por Busch, Elena, Kubon, Kristina D., Mayer, Johanna K. M., Pidelaserra-Martí, Gemma, Albert, Jessica, Hoyler, Birgit, Heidbuechel, Johannes P. W., Stephenson, Kyle B., Lichty, Brian D., Osen, Wolfram, Eichmüller, Stefan B., Jäger, Dirk, Ungerechts, Guy, Engeland, Christine E.
Publicado en Viruses (2020)

A non-controlled, single arm, open label, phase II study of intravenous and intratumoral administration of ParvOryx in patients with metastatic, inoperable pancreatic cancer: ParvO...

por Hajda, Jacek, Lehmann, Monika, Krebs, Ottheinz, Kieser, Meinhard, Geletneky, Karsten, Jäger, Dirk, Dahm, Michael, Huber, Bernard, Schöning, Tilman, Sedlaczek, Oliver, Stenzinger, Albrecht, Halama, Niels, Daniel, Volker, Leuchs, Barbara, Angelova, Assia, Rommelaere, Jean, Engeland, Christine E., Springfeld, Christoph, Ungerechts, Guy
Publicado en BMC Cancer (2017)